Sila Realty Trust Inc. Tenant Files for Bankruptcy – Goodman & Nekvasil, P.A., May Recover Investor Losses
According to the DI Wire on June 7, 2023, Sila Realty Trust, Inc. announced that GenesisCare USA Inc. filed for Chapter 11 bankruptcy protection.
GenesisCare reportedly operates 17 radiation oncology and related use properties that are owned by the REIT. GenesisCare notes that its plan for reorganization includes a sale of its U.S. business within a six-month period.
On March 6, 2023, Sila’s board recommended rejecting an unsolicited tender offer by CMG Partners.
CMG offered to purchase up to 500,000 Class A shares for $4.16 each. The offer is close to 50 percent less than the REIT’s published net asset value.
The board of directors also noted that there is a limited market for the Company’s common stock.
Sila Realty Trust Tenant Files for Bankruptcy
Goodman & Nekvasil, P.A., is investigating broker dealers who may have unsuitably recommended Sila Realty Trust to its clients.
REITs are risky and complicated investments. Goodman & Nekvasil, P.A., a Clearwater, Florida, law firm with a national practice representing victimized investors, continues to investigate brokerage firms that placed elderly retirees and other conservative investors in high-risk investments such as Sila Realty Trust.
Goodman & Nekvasil, P.A., has filed numerous cases against brokerage firms selling high-risk investments and has recovered more than $300 million dollars on behalf of victimized investors. We allege in these cases that these investment recommendations were unsuitable for our clients in view of their financial situation, needs and investment objectives.
There is no charge for an evaluation of your case. Further, we handle our cases on a contingency fee basis. This means that unless we recover money for you, we charge no attorney’s fee.
If you incurred losses on your investment in Sila Realty Trust, Inc. and would like your case evaluated by a securities attorney, please contact us.
Some of the information in this blog post was obtained from published news articles. If you believe this information was reported incorrectly, please contact our firm: 1-800-500-4442.